Literature DB >> 23645451

Using patients like my patient for clinical decision support: institution-specific probability of celiac disease diagnosis using simplified near-neighbor classification.

Brian H Shirts1, Sterling T Bennett, Brian R Jackson.   

Abstract

BACKGROUND: Interpretation of a diagnostic test result requires knowing what proportion of patients with a "similar" result has the condition in question. This information is often not readily available from the medical literature, or may be based on different clinical populations that make it nonapplicable. In certain settings, where correlated screening parameters and diagnostic data are available in electronic medical records, a representation of diagnostic test performance on "patients like my patient" can be obtained.
OBJECTIVE: We sought to integrate patient demographic and physician practice information using a simplified nearest neighbor algorithm. We used this method to illustrate the relationship between tTG IgA test result and duodenal biopsy for celiac disease in a local diagnostic context. PARTICIPANTS: We used a data set of 1,461 paired tissue transglutaminase (tTG) IgA and definitive duodenal biopsy results from Intermountain Healthcare with data on patient age and ordering physician specialty. This was split into a discovery set of 1,000 and a validation set of 461 paired results. MAIN MEASURES: Accuracy of the local discovery data set in predicting probability of positive duodenal biopsy and confidence intervals around predicted probability in the test data compared to probabilities of positive biopsy implied from published logistic regression and from published sensitivity and specificity studies. KEY
RESULTS: The near-neighbor method could estimate probability of clinical outcomes with predictive performance equivalent to other methods while adjusting probability estimates and confidence intervals to fit specific clinical situations.
CONCLUSIONS: Data from clinical encounters obtained from electronic medical records can yield prediction estimates that are tailored to the individual patient, local population, and healthcare delivery processes. Local analysis of diagnostic probability may be more clinically meaningful than probabilities inferred from published studies. This local utility may come at the expense of external validity and generalizability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23645451      PMCID: PMC3832711          DOI: 10.1007/s11606-013-2443-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  22 in total

Review 1.  Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review.

Authors:  Daniëlle A W M van der Windt; Petra Jellema; Chris J Mulder; C M Frank Kneepkens; Henriëtte E van der Horst
Journal:  JAMA       Date:  2010-05-05       Impact factor: 56.272

Review 2.  Update on serologic testing in celiac disease.

Authors:  Daniel A Leffler; Detlef Schuppan
Journal:  Am J Gastroenterol       Date:  2010-12       Impact factor: 10.864

3.  Positive predictive value of serological diagnostic measures in celiac disease.

Authors:  Peter Toftedal; Christian Nielsen; Jonas Trolle Madsen; Kjell Titlestad; Steffen Husby; Søren Thue Lillevang
Journal:  Clin Chem Lab Med       Date:  2010-05       Impact factor: 3.694

4.  How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease.

Authors:  Alberto Ravelli; Vincenzo Villanacci; Chiara Monfredini; Silvia Martinazzi; Veronica Grassi; Stefania Manenti
Journal:  Am J Gastroenterol       Date:  2010-04-06       Impact factor: 10.864

5.  Regional variations in diagnostic practices.

Authors:  Yunjie Song; Jonathan Skinner; Julie Bynum; Jason Sutherland; John E Wennberg; Elliott S Fisher
Journal:  N Engl J Med       Date:  2010-05-12       Impact factor: 91.245

Review 6.  Interventions for improving the adoption of shared decision making by healthcare professionals.

Authors:  France Légaré; Stéphane Ratté; Dawn Stacey; Jennifer Kryworuchko; Karine Gravel; Ian D Graham; Stéphane Turcotte
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

7.  Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.

Authors:  Santiago Vivas; Jose G Ruiz de Morales; Sabino Riestra; Laura Arias; Dolores Fuentes; Noemi Alvarez; Sara Calleja; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Luis Rodrigo
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

8.  What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

Authors:  Andrew D Hopper; Marios Hadjivassiliou; David P Hurlstone; Alan J Lobo; Mark E McAlindon; William Egner; Graeme Wild; David S Sanders
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03       Impact factor: 11.382

9.  Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?

Authors:  A D Hopper; S S Cross; D S Sanders
Journal:  Endoscopy       Date:  2008-12-05       Impact factor: 10.093

10.  Adaptive informatics for multifactorial and high-content biological data.

Authors:  Bjorn L Millard; Mario Niepel; Michael P Menden; Jeremy L Muhlich; Peter K Sorger
Journal:  Nat Methods       Date:  2011-04-24       Impact factor: 28.547

View more
  2 in total

1.  Medicine based upon data.

Authors:  Charles Safran
Journal:  J Gen Intern Med       Date:  2013-12       Impact factor: 5.128

2.  Clinical laboratory analytics: Challenges and promise for an emerging discipline.

Authors:  Brian H Shirts; Brian R Jackson; Geoffrey S Baird; Jason M Baron; Bryan Clements; Ricky Grisson; Ronald George Hauser; Julie R Taylor; Enrique Terrazas; Brad Brimhall
Journal:  J Pathol Inform       Date:  2015-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.